De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Clorox Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
Clorox heeft een totaal eigen vermogen van $492.0M en een totale schuld van $2.5B, wat de schuld-eigenvermogensverhouding op 505.1% brengt. De totale activa en totale passiva bedragen respectievelijk $5.8B en $5.3B. De EBIT Clorox is $921.0M waardoor de rentedekking 13.7 is. Het heeft contanten en kortetermijnbeleggingen van $202.0M.
Belangrijke informatie
505.1%
Verhouding schuld/eigen vermogen
US$2.49b
Schuld
| Rente dekkingsratio | 13.7x |
| Contant | US$202.00m |
| Aandelen | US$492.00m |
| Totaal verplichtingen | US$5.26b |
| Totaal activa | US$5.75b |
Recente financiële gezondheidsupdates
Is Clorox (NYSE:CLX) A Risky Investment?
May 25
Is Clorox (NYSE:CLX) Using Too Much Debt?
Feb 09Clorox (NYSE:CLX) Seems To Use Debt Quite Sensibly
Oct 16Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet
Jul 15Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet
Apr 07Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet
Jan 05Recent updates
Why We're Not Concerned About The Clorox Company's (NYSE:CLX) Share Price
Sep 21Clorox: If You Need FMCG Player In A Portfolio - Look Elsewhere
Sep 15Clorox (NYSE:CLX) Will Pay A Larger Dividend Than Last Year At $1.22
Aug 03Here's What To Make Of Clorox's (NYSE:CLX) Decelerating Rates Of Return
Jul 29Clorox: Stellar Delivery But Valuation Compression Has Some Distance To Go
Jul 29Clorox: Questionable Growth Target Puts Me On The Sidelines
Jul 17Clorox: Improving Outlook, Good Dividend Yield And Discounted Valuation
Jun 28Is Clorox (NYSE:CLX) A Risky Investment?
May 25We Like The Quality Of Clorox's (NYSE:CLX) Earnings
May 07Clorox (NYSE:CLX) Could Be At Risk Of Shrinking As A Company
Apr 26Colgate-Palmolive: Improved Financials To Navigate Headwinds (Rating Upgrade)
Apr 21Is There An Opportunity With The Clorox Company's (NYSE:CLX) 31% Undervaluation?
Apr 10Is Clorox (NYSE:CLX) Using Too Much Debt?
Feb 09Clorox: Relatively Overvalued And Headwinds Put Dividend At Risk
Feb 08The Clorox Company's (NYSE:CLX) Popularity With Investors Is Under Threat From Overpricing
Jan 25Is The Clorox Company (NYSE:CLX) Trading At A 27% Discount?
Jan 07Clorox: Not Wiped Out By Cyber Attack, Earnings And Revenue Need Cleaning Up
Jan 03Be Wary Of Clorox (NYSE:CLX) And Its Returns On Capital
Dec 18Clorox: One Of The Best Household Product Portfolios
Dec 01The Clorox Company's (NYSE:CLX) CEO Might Not Expect Shareholders To Be So Generous This Year
Nov 09Clorox: Undervalued But Too Many Red Flags
Oct 28Clorox (NYSE:CLX) Seems To Use Debt Quite Sensibly
Oct 16Clorox: Cyberattack Compounds Existing Challenges
Oct 10Clorox's (NYSE:CLX) Shareholders Will Receive A Bigger Dividend Than Last Year
Oct 01Clorox: Still Struggling
Sep 25Are Investors Undervaluing The Clorox Company (NYSE:CLX) By 35%?
Sep 21Returns On Capital Signal Difficult Times Ahead For Clorox (NYSE:CLX)
Sep 03The Clorox Company: The Necessary Clean-Up Has Only Begun
Aug 30Despite Earnings Rally, Expectations On Clorox Are Low
Aug 15Clorox's (NYSE:CLX) Upcoming Dividend Will Be Larger Than Last Year's
Jul 31Clorox: Stable Growth Prospects But Pricey
Jul 20Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet
Jul 15Keeping My Portfolio Clean By Avoiding Clorox
Jul 06Colgate-Palmolive: Stagnation And Debt-Fueled Dividends
Jun 01Here's What's Concerning About Clorox's (NYSE:CLX) Returns On Capital
May 31Estimating The Fair Value Of The Clorox Company (NYSE:CLX)
Apr 25Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet
Apr 07Clorox: Finally Emerging From The Pandemic Shadows
Feb 21Clorox declares $1.18 dividend
Feb 15The Clorox Company: Dividend Income Seekers Avoid Buying
Feb 09Be Wary Of Clorox (NYSE:CLX) And Its Returns On Capital
Feb 05Estimating The Intrinsic Value Of The Clorox Company (NYSE:CLX)
Jan 20Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet
Jan 05The Clorox Company: High Valuations And Near-Term Headwinds Keep Me On The Sidelines
Dec 27Clorox declares $1.18 dividend
Nov 16Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $1.6B ) CLX } overtreffen de korte termijn passiva ( $1.6B ).
Langlopende schulden: De kortetermijnactiva van CLX ( $1.6B ) dekken de langetermijnschulden ( $3.7B ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 464% ) CLX wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van CLX is de afgelopen 5 jaar gestegen van 480% naar 505.1%.
Schuldendekking: De schuld van CLX wordt goed gedekt door de operationele kasstroom ( 28% ).
Rentedekking: De rentebetalingen op de schuld van CLX worden goed gedekt door EBIT ( 13.7 x dekking).